Internal Medicine, Geriatric Medicine · San Diego, CA
NPI
1184958977
Since 2009
Specialty
Internal Medicine, Geriatric Medicine
Code 207RG0300X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
7801 Mission Center Ct Ste 310
San Diego, CA, 92108
Phone (619) 795-8346
Groups this clinician bills Medicare through
Medicare paid, 2023
$16K
155 services
Medicare patients, 2023
88
Average age 72
Drug cost, 2024
$720K
7,645 prescriptions
Company payments, 2025
$62.64
From 2 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Pouya Afshar was code 99310 (snf e&m), 41 times for 34 patients. In total Pouya Afshar billed 155 services in 13 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99310 SNF E&M | Facility | 41 | 34 | $127.89 | $5,243 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 35 | 24 | $52.90 | $1,852 |
| 99350 Home E&M - New and Established | Facility | 34 | 16 | $144.41 | $4,910 |
By year: 2022 $36K for 122 services; 2023 $16K for 155 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pouya Afshar prescribed most often to Medicare patients was Atorvastatin Calcium, with 445 prescriptions and refills. In total Pouya Afshar wrote 7,645 Medicare prescriptions that cost $720K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 445 | 449 | 89 | $7,172 |
| Eliquis Apixaban | 383 | 383 | 55 | $114K |
| Gabapentin Generic | 369 | 371 | 67 | $8,028 |
| Levothyroxine Sodium Generic | 312 | 313 | 44 | $3,645 |
| Famotidine Generic | 227 | 230 | 37 | $4,157 |
| Amlodipine Besylate Generic | 210 | 211 | 50 | $1,717 |
| Tamsulosin Hcl Generic | 159 | 161 | 30 | $2,808 |
| Mirtazapine Generic | 132 | 133 | 21 | $4,413 |
| Carvedilol Generic | 131 | 132 | 26 | $1,392 |
| Xarelto Rivaroxaban | 127 | 127 | Under 11 | $39K |
| Metformin Hcl Generic | 122 | 123 | 29 | $1,356 |
| Pantoprazole Sodium Generic | 113 | 114 | 30 | $1,578 |
| Trazodone Hcl Generic | 108 | 109 | 28 | $1,235 |
| Levetiracetam Generic | 105 | 105 | 15 | $5,496 |
| Losartan Potassium Generic | 97 | 98 | 27 | $1,073 |
Brand drugs: - claims; generic drugs: 6,077 claims; opioid claims: 77.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pouya Afshar $62.64 ($62.64 in general payments such as food, travel and fees) from 2 companies. The largest payer was Neurocrine BioSciences, Inc. with $31.55.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.